Association between PSA declines at 4 weeks and OS in patients treated with abiraterone acetate (AA) for metastatic castration resistant prostate cancer (mCRPC) after docetaxel.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Pasquale Rescigno, David Lorente, Roberta Ferraldeschi, Diletta Bianchini, Spyridon Sideris, Zafeiris Zafeiriou, Alan David Smith, Niven Mehra, Emily Grist, Anuradha Jayaram, Michael Paul Kolinsky, Raquel Perez Lopez, Joaquin Mateo, Chris Parker, David Paul Dearnaley, Emma Hall, Nina Tunariu, Gerhardt Attard, Johann Sebastian De Bono
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589560008